Literature DB >> 6821116

Bacteremia in children following upper gastrointestinal endoscopy or colonoscopy.

W J Byrne, A R Euler, M Campbell, K D Eisenach.   

Abstract

Fifty children undergoing upper gastrointestinal endoscopy and 25 undergoing colonoscopy were studied prospectively with aerobic and anaerobic blood cultures for the development of bacteremia. Twenty-six of the endoscopies and all the colonoscopies were done under general anesthesia. Cultures were obtained before, at 5 min, and at 30 min after the procedure. Only a single positive blood culture was obtained in an upper endoscopy patient. All cultures from the colonoscopy patients were negative. Biopsy or polypectomy were not important variables in the development of bacteremia. It is concluded that the risk of bacteremia in children following upper endoscopy or colonoscopy is minimal and should not be considered a contraindication to their performance.

Entities:  

Mesh:

Year:  1982        PMID: 6821116     DOI: 10.1097/00005176-198212000-00017

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  4 in total

1.  Complications of pediatric colonoscopy: a five-year multicenter experience.

Authors:  Kalpesh Thakkar; Hashem B El-Serag; Nora Mattek; Mark Gilger
Journal:  Clin Gastroenterol Hepatol       Date:  2008-03-20       Impact factor: 11.382

2.  Obtaining research biopsies during pediatric colonoscopy: Safety and adverse events.

Authors:  Jennifer Mait-Kaufman; Stacie Kahn; Gitit Tomer
Journal:  World J Gastrointest Endosc       Date:  2015-06-25

Review 3.  Prophylaxis for infective endocarditis. Who needs it? How effective is it?

Authors:  N Press; V Montessori
Journal:  Can Fam Physician       Date:  2000-11       Impact factor: 3.275

4.  Diagnostic upper GI endoscopy for hemetemesis in children: experience from a pediatric gastroenterology centre in north India.

Authors:  S K Mittal; K K Kalra; V Aggarwal
Journal:  Indian J Pediatr       Date:  1994 Nov-Dec       Impact factor: 1.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.